Literature DB >> 6466539

Therapy with high dose recombinant alpha 2 interferon (IFN-alpha 2) produces a depression in natural killer cell cytotoxicity.

B Tank, R L Marquet, W Weimar, D L Westbroek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6466539      PMCID： PMC1976876          DOI： 10.1038/bjc.1984.167

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  12 in total

1.  Natural cell-mediated cytotoxicity in rats. III. Effects of immunopharmacologic treatments on natural reactivity and on reactivity augmented by polyinosinic-polycytidylic acid.

Authors:  J R Oehler; R B Herberman
Journal:  Int J Cancer       Date:  1978-02-15       Impact factor: 7.396

2.  Cytotoxic reactivity of human lymphocytes cultured in vitro.

Authors:  J R Ortaldo; G D Bonnard; R B Herberman
Journal:  J Immunol       Date:  1977-10       Impact factor: 5.422

3.  Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity.

Authors:  R R Herberman; J R Ortaldo; G D Bonnard
Journal:  Nature       Date:  1979-01-18       Impact factor: 49.962

4.  Purification and characterization of recombinant human leukocyte interferon (IFLrA) with monoclonal antibodies.

Authors:  T Staehelin; D S Hobbs; H Kung; C Y Lai; S Pestka
Journal:  J Biol Chem       Date:  1981-09-25       Impact factor: 5.157

5.  Modulation of natural killer cell-mediated cytotoxicity by partially purified and cloned interferon-alpha.

Authors:  E Lotzová; C A Savary; J U Gutterman; E M Hersh
Journal:  Cancer Res       Date:  1982-06       Impact factor: 12.701

6.  Enhancement by interferon of lymphocyte cytotoxicity in normal individuals to cells of human lymphoblastoid lines.

Authors:  S V Skurkovich; A S Skorikova; E I Eremkina
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

7.  Electrophoretically pure mouse interferon exerts multiple biologic effects.

Authors:  I Gresser; J De Maeyer-Guignard; M G Tovey; E De Maeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

8.  Depression of natural killer cytotoxicity after in vivo administration of recombinant leukocyte interferon.

Authors:  A E Maluish; J R Ortaldo; J C Conlon; S A Sherwin; R Leavitt; D M Strong; P Weirnik; R K Oldham; R B Herberman
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

9.  Human natural killer cell activity is augmented by interferon via recruitment of 'pre-NK' cells.

Authors:  E Saksela; T Timonen; K Cantell
Journal:  Scand J Immunol       Date:  1979       Impact factor: 3.487

10.  Induction and kinetics of natural killer cells in humans following interferon therapy.

Authors:  J R Huddlestone; T C Merigan; M B Oldstone
Journal:  Nature       Date:  1979-11-22       Impact factor: 49.962
View more
  2 in total

1.  A phase I toxicity study of human rDNA interferon in patients with solid tumours.

Authors:  J Wagstaff; G Chadwick; A Howell; N Thatcher; J H Scarffe; D Crowther
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

2.  Clinical and immunological evaluation of 20 patients with advanced colorectal cancer treated with high dose recombinant leukocyte interferon-alpha A (rIFN alpha A).

Authors:  A M Eggermont; W Weimar; B Tank; A M Dekkers-Bijma; R L Marquet; J S Lameris; D L Westbroek; J Jeekel
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.